Global /Japan /Healthcare /Drug Manufacturers - General /4538

Fuso Pharmaceutical Industries,Ltd.

4538

• TSE: 4538 • Delayed

2,219JPY -0.2%

13.85 USD

As of 6 June 2026, Fuso Pharmaceutical Industries,Ltd. has a market cap of $118.6M USD, ranking #24371 globally and #2100 in Japan. It ranks #2182 in the Healthcare sector, and #792 in the Drug Manufacturers - General industry.

Global Rank

24371

Country Rank

2100

Sector Rank

2182

Industry Rank

792

Key Stats

Market Cap

$118.6MUSD

18.98B JPY

Enterprise Value

$286.11MUSD

45.82B JPY

Revenue (TTM)

$388.49MUSD

62.17B JPY

Net Income (TTM)

$12.89MUSD

2.06B JPY

Profit Margin

3.3%

PE Ratio

9.2

PS Ratio

0.3

PB Ratio

0.5

Company Profile

Country (HQ)

Japan

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Mikio Toda open_in_new

Employees

1,370

Founded

1937

Website

fuso-pharm.co.jp open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.2%	-1.9%	-8.3%	-3.9%	1%	-4%	-5.1%	11%	-8.9%

News

Markets

Exchange	Ticker	Price	Quotes
Tokyo Stock Exchange (TSE / TYO) MIC: XTKS PRIMARY	4538 扶桑薬品工業株式会社 ISIN: JP3823600006 Shares Out.: Shares Outstanding: 8.537M¹ Shares Float: 5.088M² TV: TradingView: TSE: 4538 SA: Stock Analysis: TYO: 4538 YF: Yahoo Finance: 4538.T GF: Google Finance: TYO: 4538 BA: Barron's: 4538 MS: Morningstar: XTKS: 4538	2,219 JPY	TV: TradingView: TSE: 4538 SA: Stock Analysis: TYO: 4538 YF: Yahoo Finance: 4538.T GF: Google Finance: TYO: 4538 BA: Barron's: 4538 MS: Morningstar: XTKS: 4538

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Fuso Pharmaceutical Industries,Ltd.

Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceuticals and medical equipment in Japan. The company offers injectables, infusions, and dialysis agents for artificial kidneys, as well as medical equipment and devices. It also engages in the contract manufacturing of drugs; and real estate leasing businesses. The company was incorporated in 1937 and is based in Osaka, Japan.

Similar Companies

Industry: Drug Manufacturers - General (Japan)

Name	Market Cap (USD) diff.	PE	Country
Chugai Pharmaceutical Co., Ltd. TSE: 4519	$81.66B 13.07T JPY 69K%	28.9	Japan
Takeda Pharmaceutical Company Ltd. TSE: 4502	$52.21B 8.36T JPY 44K%	75.1	Japan
Otsuka Holdings Co., Ltd. TSE: 4578	$36.84B 5.9T JPY 31K%	15.7	Japan
Daiichi Sankyo Company, Ltd. TSE: 4568	$30.37B 4.86T JPY 26K%	16.2	Japan
Astellas Pharma Inc. TSE: 4503	$25.82B 4.13T JPY 22K%	14.2	Japan
Shionogi & Co., Ltd. TSE: 4507	$16.91B 2.71T JPY 14K%	13.9	Japan

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 642K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 461K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 304K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 274K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 244K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 234K%	20.5	Switzerland

chevron_leftBack